Royalty Pharma Plc
RPRX
$59.81+1.39%
Delayed · as of Oct 15, 2026, 2:01 PM ET
Mkt cap
$20.45B
EV/Sales
12.1
P/E ratio
N/A
FY2025 Revenue
$2.38B
EPS (TTM)
$1.87
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
32.42%
Beta
0.47
Div yield
2.44%
Sector
Healthcare
Royalty Pharma Plc (RPRX) is a biotechnology company listed on US.
Latest reported RPRX revenue for 2025-12-31 was $2.38B. Net income was $770.9M. Revenue was up 5.1% from 2024-12-31 to 2025-12-31. RPRX currently screens at market cap $20.45B.
Use this RPRX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full RPRX income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Royalty Pharma Plc (RPRX) is a biotechnology company in the Healthcare sector.
Latest cached Royalty Pharma Plc (RPRX) revenue for Dec 31, 2025 was $2.38B. Net income was $770.9M. Statements: https://lician.com/financials/rprx
Royalty Pharma Plc (RPRX) market capitalization is $20.45B on the latest cached snapshot.
Royalty Pharma Plc (RPRX) cached previous close $58.99; day range $59.75 – $59.81; volume 1,476,699. Session quote: https://lician.com/quote/rprx
Royalty Pharma Plc (RPRX) latest cached earnings event is "RPRX earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached RPRX filing is 8-K · Aug 5, 2026. Filings: https://lician.com/sec/rprx